Key Highlights
- TSLA shares advanced 3.2% following UBS’s decision to increase its price target from $364 to $442 while maintaining a neutral stance
- Shares reached an intraday peak of $407.86, aligning closely with Wall Street’s consensus target of $406.87
- The electric vehicle manufacturer delivered a record 480,126 vehicles in Q2 2026, surpassing several analyst projections
- AlpenGlobal Capital established a fresh position valued at $13.35 million, representing 8.7% of their total portfolio
- Wall Street analysts are evenly divided with 21 Buy, 21 Hold, and 4 Sell ratings; quarterly results expected July 22
Shares of Tesla (TSLA) advanced 3.2% during Thursday’s trading session after UBS analysts elevated their price target from $364 to $442, while maintaining their neutral outlook on the electric vehicle giant. The surge sent TSLA to an intraday high of $407.86 before settling at $406.55, up from its opening price of $394.06.
UBS’s revision wasn’t an isolated event. RBC Capital followed suit by lifting their target from $475 to $500 while reaffirming an Outperform rating, emphasizing Tesla’s artificial intelligence capabilities and autonomous vehicle potential as primary catalysts.
However, not all analyst perspectives are uniformly positive. Citizens recently launched coverage with a Market Perform designation, cautioning that investor enthusiasm surrounding Tesla’s autonomous technology may be outpacing realistic commercialization schedules.
Wall Street sentiment shows clear division. Current analyst ratings include 21 Buy recommendations, 21 Hold positions, and 4 Sell calls, producing a consensus price target of $406.87.
Tesla’s second-quarter 2026 performance provided encouraging signals for optimistic investors. The company achieved record-breaking deliveries totaling 480,126 vehicles alongside production of 451,758 units. Additionally, the Model Y regained its position as China’s best-selling vehicle during June.
Beyond automotive sales, Tesla’s energy storage division continues gaining traction. The company has accumulated over $9 billion in Megapack orders, creating an additional revenue stream independent of its primary vehicle business.
Growing Institutional Ownership
AlpenGlobal Capital LLC revealed a newly established Tesla position during the first quarter, acquiring 35,911 shares valued at approximately $13.35 million. This investment now constitutes roughly 8.7% of AlpenGlobal’s entire portfolio, marking it as their most significant individual holding.
Institutional investors collectively control approximately 66.2% of Tesla’s total outstanding shares. Multiple additional firms have expanded their TSLA positions in recent months, including Brighton Jones, Revolve Wealth Partners, and Bison Wealth.
Insider transactions have trended in the opposite direction. Chief Financial Officer Vaibhav Taneja divested 2,606 TSLA shares at an average price of $402.20 in June, representing a 10.57% reduction in his holdings. This transaction was associated with tax liabilities from vesting equity awards. Board member Kathleen Wilson-Thompson similarly sold 26,409 shares at $378.11 in late April, decreasing her position by 35.3%.
Upcoming July 22 Earnings Report
Tesla’s next quarterly earnings announcement is scheduled for July 22. During the previous quarter (Q1), the company delivered earnings per share of $0.41, exceeding the consensus forecast of $0.39. Revenue totaled $22.39 billion, marginally below analyst expectations of $22.96 billion, though representing a 15.8% year-over-year increase.
Wall Street analysts project Tesla will achieve full-year EPS ranging from $1.29 to $1.30 for fiscal 2026.
The stock currently trades with a price-to-earnings ratio near 374, a PEG ratio of 14.89, and commands a market capitalization of $1.53 trillion. Its 52-week trading range extends from $297.82 to $498.83.
Regulatory challenges persist as potential headwinds. Proposed legislation in New Jersey could impose limitations on Tesla’s autonomous driving capabilities, while ongoing examination of Elon Musk’s SEC settlement continues drawing regulatory attention.
Morgan Stanley reaffirmed an Equal Weight rating with a $415 price objective on July 2.


